Pasi Antero Janne, M.D.,Ph.D.
This page shows the publications co-authored by Pasi Janne and Heidi Haikala.
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd. Cancer Res. 2022 01 01; 82(1):130-141.
Thirty Years of HER3: From Basic Biology to Therapeutic Interventions. Clin Cancer Res. 2021 07 01; 27(13):3528-3539.
A novel HER2-selective kinase inhibitor is effective in HER2 mutant and amplified non-small cell lung cancer. Cancer Res. 2022 Feb 11.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.